Table 2.
Common 3D bioprinting modalities.
| 3D bioprinting modality | Description | Resolution range | Advantages | Disadvantages | Applications | Refs. |
|---|---|---|---|---|---|---|
| Conventional extrusion bioprinting | Compressed air or mechanical screw or piston drives the bioink through a nozzle | 100–2000 μm | Multi-material bioprinting; high scalability; high cell density; cost-effective | Nozzle clogging; moderate cell viability due to shear stress | To biofabricate 3D tissue structures in a layer-by-layer manner | [247, 248, 265–267] |
| Co-axial bioprinting | Simultaneous extrusion of bioinks and crosslinker solution through coaxial nozzle | 200–2000 μm | Complex setup; challenges in tuning flow rates for each bioink simultaneously | To biofabricate standalone solid or hollow tubular fibers | [249, 268–272] | |
| Embedded bioprinting | Extrusion of bioink into supportive bath into a support bath that holds the bioprinted structure. | ~20 μm | Challenges in removal of support matrix; may require additional processing steps | To biofabricate complex tissue structures using mechanically weak bioinks | [249, 276–279, 283] | |
| Chaotic bioprinting | Chaotic flow of two or more bioinks using a nozzle equipped with a Kenics static mixer | ~10 μm | Nozzle clogging; moderate cell viability due to shear stress; not suitable for high-viscosity bioinks | To generate continuous fibers with internally aligned lamellar microstructures | [294, 295, 300–302] | |
| Inkjet-based bioprinting | Electrically heated printhead or piezoelectric actuator ejects small droplets of bioink out of the nozzle | ~50 μm | High bioprinting speed; precise deposition of bioink droplets; cost-effective | Low cell viability; non-uniform droplets; printhead clogging; requires low cell density and low viscosity bioinks | To biofabricate tissue scaffolds by precise placement of small droplets of bioink onto a substrate | [250, 303–305, 308, 312, 314–316] |
| Stereolithography | Either single- or two-photon laser and raster scanning selectively that cures a bioink in a point-by-point manner | ~1 μm | Nozzle-free; relatively fast bioprinting speed; high cell viability | Requires photocurable bioinks; moderate cost | To biofabricate tissue structures by exposing bioink to the laser that selectively cures a bioink in a point-by-point manner | [317–320] |
| Digital light processing | Either UV or visible light prepatterned from a projector selectively that cures the bioink in a layer-by-layer manner | ~35–100 μm | To biofabricate tissue structures by exposing light through a digital mask or pattern onto the surface of the bioink in a layer-by-layer manner | [256, 318, 329, 330] | ||
| Volumetric bioprinting | Simultaneous exposure of UV or visible light onto a rotating vat of bioink that creates a desired structure in a single step | ~40–100 μm | To biofabricate geometrically complex tissue construct in a centimeter-scale in a single step. | [253, 336–339] | ||
| Laser-assisted bioprinting | Precise deposition of the bioink onto a substrate using laser pulses | ~10–100 μm | High precision; relatively fast bioprinting speed; high cell density | Limited cell viability; requires high-viscosity bioinks; comparatively high cost | To facilitate tissue regeneration via bioprinting using single cells or cell aggregates | [258, 345, 351, 352] |
| Kenzan bioprinting | Precise positioning of spheroids within a microneedle array to fused into tissue constructs | Spheroids of ~500 μm in diameter are fused to form larger tissue constructs | High cell density; high cell viability; may not require supporting biomaterial scaffold | Requires pre-fabrication of spheroids; complex bioprinting setup; may induce damage due to needle | To biofabricate tissue structures utilizing cell spheroids as the fundamental building blocks | [262, 356, 357] |